Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Editorial
Erratum
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medial Education
Medical Education
Obituary
Opinion Article
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Editorial
Erratum
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medial Education
Medical Education
Obituary
Opinion Article
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Editorial
Erratum
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medial Education
Medical Education
Obituary
Opinion Article
Original Article
Review Article
Short Communication
View/Download PDF

Translate this page into:

Original Article
65 (
2
); 109-114
doi:
10.25259/IJPP_85_2021

Correlation of Serum Ferritin and Adenosine Deaminase with Body Mass Index in Children: A cross-sectional study

Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
MBBS student, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

*Corresponding author: Joseph John, Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India. ped_joseph@aiimsbhubaneswar.edu.in

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Sahu S, Menon M, John J. Correlation of Serum Ferritin and Adenosine Deaminase with Body Mass Index in Children: A cross-sectional study. Indian J Physiol Pharmacol 2021;65(2):109-14.

Abstract

Objectives:

The objectives of the study were to correlate the levels of two markers of inflammation, serum Ferritin and adenosine deaminase (ADA), with anthropometric measurements in children.

Materials and Methods:

This cross-sectional study was performed in a total of 60 apparently healthy children (30 in each group), aged 6–14 years whose anthropometric measurements were taken and grouped as normal and obese as per body mass index (BMI), and their serum levels of ADA, Ferritin and Lipids were analyzed.

Results:

Serum Ferritin, ADA, total cholesterol, and low-density lipoprotein cholesterol levels were significantly higher in the obese compared to normal children. The systolic blood pressure (SBP) was significantly higher in obese children, though the diastolic BP was similar across the groups. There was a strong positive correlation of the SBP, serum Ferritin and ADA with BMI. Ferritin showed a statistically significant positive correlation with waist circumference, hip circumference, waist-hip ratio (WHR), and triceps skinfold thickness. ADA, too, positively correlated with all anthropometric values, though it was statistically significant only with the SBP and WHR.

Conclusion:

Serum Ferritin and ADA, which are markers of inflammation, were elevated in obese children compared to normal children. These biochemical markers may predict non-communicable diseases than cumbersome markers like anthropometric indices in the future.

Keywords

Obesity
Inflammation
Non-communicable diseases
Body mass index
Body weight
Lipids

INTRODUCTION

Obesity plays a pivotal role in the etiology of numerous non-communicable diseases (NCD’s). The worldwide prevalence of obesity has tripled in the last few decades, with children in the age group of 5–19 years contributing an overwhelming number of 340 million.[1] Childhood weight gain leads to adulthood obesity, and in turn, increases the risk of adult NCD’s. Low to medium income countries like India have a unique problem of “double burden” wherein, on one hand, we have poverty and under-nutrition,[2] and on the other, obesity.[3]

A large number of pro-inflammatory intermediaries are released by adipocytes and immune cells, causing low grade inflammation. These inflammatory mediators are involved in chronic systemic inflammation, insulin resistance, and atherosclerosis which leads to NCD’s such as type 2 diabetes, cardiovascular disease, hypertension, polycystic ovarian syndrome, certain cancers, and even severe asthma.[4] Adipose tissue synthesizes adenosine in response to inflammation to work as an anti-inflammatory metabolite. Adenosine deaminase (ADA), an enzyme of purine metabolism, converts adenosine to inosine. ADA plays a role in patients with metabolic syndromes such as obesity, insulin resistance, fasting hyperglycemia, dyslipidemia, and hypertension.[5] Evidence on serum ADA levels and ADA gene polymorphism in patients with insulin resistance and diabetes suggest its high levels in subjects with obesity as well.[5] Obesity being a subclinical mild inflammatory condition, there is evidence correlating C-reactive protein with body mass index (BMI), but there are conflicting reports amongst adults correlating BMI with iron status,[6,7] serum Ferritin[8-11] and hemoglobin.[12]

Keeping these in mind, the present study was designed to correlate serum ADA and Ferritin levels with BMI and other anthropometric measurements in children. In addition, the components of metabolic syndrome (i.e. lipid profile and age-matched blood pressure [BP]) were evaluated with these biochemical parameters.

MATERIALS AND METHODS

This cross-sectional study was conducted in the Departments of Paediatrics and Biochemistry at a tertiary care teaching hospital in Eastern India from April 2019 to September 2019. Ethical approval was obtained from the Institute Ethics Committee vide letter number IEC/AIIMS BBSR/STS/2019-20/01. The study population included children of 6–14 years of age attending the outpatient department. The inclusion criteria were: apparently healthy children who had come for assessment of refractive errors or were attending the vaccination clinic without any known chronic diseases or ailments. These children and their parents were explained the details of the study. Written informed consent was obtained from the parents, and assent obtained from children >7 years of age. History was elicited, and a physical examination performed, which ruled out an acute illness within the past month or an identifiable chronic disease. Those with a history of chronic diseases, for example, allergies such as childhood asthma, chronic lung disease, celiac disease, nephrotic syndrome, chronic kidney disease, history of jaundice suggesting a liver disease, psychiatric illness, hemoglobinopathies, bleeding disorders, malignancies, epilepsy, juvenile diabetes mellitus, long-term medication use, treatment for anemia with hematinics, an infection causing a febrile illness in the previous month, or anemia on clinical examination were excluded from the study as these conditions could indirectly affect serum levels of Ferritin and ADA.

A single trained observer recorded weight and height as per standard guidelines using the same digital weighing scale with a minimum graduation of 10 g and a stadiometer with a minimum graduation of 1 mm. From the above two records, BMI was calculated and plotted on the age and sex-specific Indian Academy of Paediatrics BMI charts for children between 5 and 18 years.[13] The children were divided into the following groups – obese or normal as follows, those with a BMI of >27 adult equivalent matched to the age- and sex-specific growth chart were labeled as obese, and those below 23 adult equivalent but above the 3rd percentile were categorized as normal[13] and were included in the healthy control group.

The triceps skinfold thickness (TST) was measured using Harpenden’s skinfold calipers (Baty International, West Sussex, UK) with a measuring range of 0–80 mm, measuring pressure: 10 g/mm2 (constant over range), accuracy of 99% and minimum graduation of 1 mm. Healthy undamaged, uninfected dry skin with relaxed muscles of the right arm was ensured, an exception for which was if there was a deformity or missing limb wherein the left side was used. The skinfold site was marked using a pen with water-soluble ink after accurately determining the mid-point between the acromion and the olecranon with a tape measure. The skinfold was firmly grasped with the thumb and index finger while gently pulling the skinfold away from the body. The caliper was placed perpendicular to the fold, on the site marked with the dial facing upwards, at approximately 1 cm below the finger and thumb. While maintaining the grasp of the skinfold, the caliper was released so that full tension was placed on the skinfold. The dial was read to the nearest 0.50 mm, 1–2 s after the grip had been fully released. Three measurements were taken, and the mean value calculated.[14] Waist circumference (WC) was measured as the narrowest circumference between the rib cage and the superior border of the iliac crest at the end of expiration. Hip circumference (HC) was measured at the greater trochanters at the widest part of the hips[14] or around the hips at the point of greatest circumference.[15] A ratio of the above two parameters was used to find out the waist-hip ratio (WHR). The BP was measured using an electronic monitoring device after the participants have been rested in a sitting posture for 5 min or more. Three recordings of systolic BP (SBP) and diastolic BP (DBP) were taken on the right arm at 5 min intervals, and the mean was documented.[16]

Fasting blood samples were collected for biochemical testing. Total Cholesterol, Triglycerides, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were measured in the autoanalyzer AU 5800 (Beckman Coulter, Inc. USA) using ready to use reagents from the same vendor. The serum ADA levels were estimated by colorimetric method using ready to use reagents from Tulip Diagnostics (P) Ltd, India. Serum Ferritin was estimated using the Chemiluminescence Immunoassay technology in the automated analyzer ADVIA Centaur XP (Siemens Healthcare GmbH, Germany) using their reagents and calibrators; and quality controls from Randox Laboratories Ltd. were used.

Sample size calculation

A sample size of 60 was determined, with 30 in each arm of the study based on the proposition by Browne.[17]

Statistical analysis

The continuous variables were expressed as mean, standard deviation and analyzed using unpaired t-test using XLSTAT for Microsoft Excel. The coefficient of correlation (r) was calculated using Pearson’s correlation between BMI with the biochemical parameters and BP and between biochemical parameters with BP, WC, HC, WHR and TST.

RESULTS

A total of 124 children were screened and 64 excluded leaving a total of 60 children who were recruited to the study, with 30 in each group. Most exclusions were due to parental consent not being obtained, mainly in the non-obese group. More boys fell in the obese category as compared to girls. The mean age of the children was 10.233 ± 2.542 years in the non-obese group versus 10.433 ± 1.924 years in the obese group. The mean weight of the children was 28.867 ± 7.127 kg in the non-obese versus 53.608 ± 12.923 kg in the obese group, which was statistically significant. All the anthropometric measures considered except height (Weight, BMI, WC, HC, WHR, and TST) were statistically significantly higher in the obese group as compared to the non-obese group [Table 1]. The SBP was significantly higher in obese children, but the DBP was similar in both groups [Table 1]. The mean serum Ferritin in the obese group was 44.937 ± 28.439 ng/L, which was significantly higher than that in the non-obese group of 28.797 ± 14.268 ng/L. The ADA results showed a similar trend as well, with the mean values in the obese (25.298 ± 12.387 U/L) being higher than that in the non obese (18.845 ± 11.936 U/L). This difference also was statistically significant. The mean total cholesterol and LDL cholesterol levels had the following values 160.167 ± 39.975 mg/dl among the obese and 128.600 ± 39.667 mg/dl in the non-obese; 100.267 ± 23.205 mg/dl in the obese; and 84.467 ± 27.256 mg/dl amongst the non-obese, respectively; both these differences were statistically significant. The serum triglyceride levels were higher in the obese (122.867 ± 48.055 mg/dl) compared to the non-obese (108.767 ± 40.642 mg/dl) children, but this difference was not statistically significant. HDL cholesterol, which is used as a cardiovascular risk factor in adults, was similar across the two groups.

Table 1: Comparison of general characteristics anthropometric parameters, BP, and biochemical parameters amongst normal and obese children.
Parameter Non Obese (n=30) Obese (n=30) P
Boys 12 20
Girls 18 10
Age 10.233±2.542 10.433±1.924 0.732
Weight (Kg) 28.867±7.127 53.608±12.923 <0.001
Height (Centimetres) 136.800±9.286 141.650±10.564 0.064
BMI 15.517±2.581 26.399±4.455 <0.001
WC (cm) 61.558±10.086 87.404±8.072 <0.001
HC (cm) 69.159±10.405 90.253±8.183 <0.001
WHR 0.893±0.052 0.968±0.060 <0.001
Triceps Skin fold Thickness (mm) 10.533±3.598 18.467±4.321 <0.001
DBP 70.233±5.857 71.533±10.395 0.543
SBP 115.133±6.801 120.267±10.58 0.029
S. Ferritin ng/L 28.797±14.268 44.937±28.439 0.007
S. ADA U/L 18.845±11.936 25.298±12.387 0.044
T Cholesterol mg/dL 128.600±39.667 160.167±39.975 0.003
S. LDL mg/dL 84.467±27.256 100.267±23.205 0.019
S. Triglycerides mg/dL 108.767±40.642 122.867±48.055 0.225
S. HDL mg/dL 42.367±13.880 43.133±7.771 0.793

BP: Blood pressure, BMI: Body mass index, WC: Waist circumference, HC: Hip circumference, WHR: Waist/Hip ratio, DBP: Diastolic blood pressure, SBP: Systolic blood pressure, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, ADA: Adenosine deaminase

There was a strong positive correlation of the SBP, serum Ferritin and ADA with BMI [Table 2]. Statistically significant differences were not obtained for any of the parameters of lipid profile with BMI. The correlation of anthropometric measurements with Ferritin [Table 3] showed a statistically significant positive correlation with WC, HC, WHR, and TST. The positive correlation with BP was not statistically significant. All anthropometric measurements had a positive correlation with ADA [Table 3]. However, there was a statistically significant difference only with the SBP and WHR.

Table 2: Correlation of BP and biochemical parameters with BMI.
Parameter Coefficient of correlation with BMI
(r) (P)
DBP (mm Hg) 0.188 0.15
SBP (mm Hg) 0.412 0.001
S. Ferritin (ng/L) 0.341 0.008
S. ADA (U/L) 0.299 0.02
T Cholesterol (mg/dL) 0.232 0.074
S. LDL (mg/dL) 0.186 0.154
S. HDL (mg/dL) 0.019 0.884
S. Triglycerides (mg/dL) 0.111 0.72

BP: Blood pressure, BMI: Body mass index, DBP: Diastolic blood pressure, SBP: Systolic blood pressure, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, ADA: Adenosine deaminase

Table 3: Correlation of BP and anthropometric measurements with serum Ferritin and ADA.
Parameter Coefficient of correlation with
S. Ferritin S. ADA
(r) (P) (r) (P)
DBP (mm Hg) 0.085 0.512 0.236 0.070
SBP (mm Hg) 0.54 0.24 0.324 0.012
WC (cm) 0.375 0.003 0.229 0.079
HC (cm) 0.281 0.029 0.141 0.266
WHR 0.396 0.002 0.301 0.019
Triceps Skin Fold Thickness (mm) 0.302 0.019 0.226 0.083

BP: Blood pressure, DBP: Diastolic blood pressure, SBP: Systolic blood pressure, WC: Waist circumference, HC: Hip circumference, WHR: Waist/Hip ratio, ADA: Adenosine deaminase

DISCUSSION

There are some theories proposed for chronic inflammation in obesity which is a preventable risk factor for adult-onset NCD’s. Adipose tissue warrants a higher amount of oxygen than most other tissues for its normal functioning.[18] With an increase in the adipose tissue mass with obesity, there is an increased distance from its vascular supply, causing hypoxic conditions. As occurs in any tissue undergoing hypoxia, there is a triggered release of Hypoxia-Inducible Factor-1 which counters the lack of oxygen in the tissue at the acute stages.[19,20] As obesity persists chronically, this hypoxia eventually causes tissue fibrosis and a vicious cycle of inflammation.[21,22] Tissue immune cells fuel obesity-related inflammation and oxidative stress in adipose tissue.[23,24]

Our study showed that serum Ferritin, ADA, total cholesterol, and LDL cholesterol levels were significantly higher in the obese compared to normal children, which was similar to a study by Jadhav and Jain done among adults, who observed that serum ADA activity was significantly increased in overweight and obese Indian subjects as compared to controls (P < 0.0001).[25] Another Nigerian study too showed a strong association of serum ADA with BMI, lipid parameters, and glucose.[26]

Ferritin is a well-established acute phase reactant, and more specifically, it is associated with abdominal obesity and other indices of body fat distribution.[8] In a meta-analysis of Ferritin and metabolic syndrome,[27] which included 26 studies, it was seen that there is a strong positive correlation of BMI with serum ferritin levels. Similarly, our study showed a statistically significant, positive correlation of ferritin with BMI, WC, HC, WHR and TST. Adipocytokines have been implicated in increasing the synthesis and secretion of the hormone hepcidin, which inhibits intestinal iron absorption and release by tissues, causing an iron deficiency.[28] Furthermore, the low-grade inflammation in obesity, even with iron deficiency, may falsely increase ferritin levels. Another school of thought suggested that iron excess in obesity could be explained by mechanisms of insulin resistance affecting iron homeostasis,[29] causing liver damage, hyperinsulinemia, and dyslipidemia. Although the above studies were in adults and animal models, our study also showed similar results as marked differences in ferritin (P = 0.007), total cholesterol (P = 0.003), and LDL cholesterol (P = 0.019) between the two groups, that is, obese and normal children. Our estimated serum Ferritin and ADA in obese and normal children differ by a statistically significant value which can be explained by the above possible reason.

In our study, all anthropometric values positively correlated with ADA, though there was a statistically significant difference only with the SBP and WHR. Though there was a strong positive correlation of the SBP and serum Ferritin amongst adults in an article published by Lee et al.[30] who showed an incremental rise of Ferritin with hypertension in males; we could not find any similar studies in children.

CONCLUSION

Serum Ferritin and ADA, which are markers of chronic inflammation, were high in obese children compared to normal children, indicating ongoing cellular inflammation without any overt signs. Future research could be directed to follow-up of a cohort of children longitudinally and correlate their biochemical markers with NCD rather than using more cumbersome markers like anthropometric indices.

What is already known

Over nutrition and obesity causes increasing NCD’s.

Anthropometric measures are difficult to measure.

Chronic inflammation is associated with NCD’s.

WHAT THIS STUDY ADDS

Biochemical markers such as serum Ferritin and ADA are high in obese children as compared to normal children.

These markers reflect chronic inflammation and may be serially monitored to look at inflammation at the cellular level and may herald NCD’s.

These markers may replace anthropometric measures to predict development of NCD’s.

Declaration of patient consent

Institutional Review Board (IRB) permission obtained for the study.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  1. . Obesity. . Geneva: World Health Organization; Available from: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight [Last accessed on 2020 Feb 25]
    [Google Scholar]
  2. , . India: Country report on children's environmental health. Rev Environ Health. 2020;35:27-39.
    [CrossRef] [Google Scholar]
  3. , , , , , , et al. Epidemiology of childhood overweight and obesity in India: A systematic review. Indian J Med Res. 2016;143:160-74.
    [CrossRef] [Google Scholar]
  4. , , , , , . The salivary levels of leptin and interleukin-6 as potential inflammatory markers in children obesity. PLoS One. 2019;14:e0210288.
    [CrossRef] [Google Scholar]
  5. , , , , . G22A polymorphism of adenosine deaminase and its association with biochemical characteristics of gestational diabetes mellitus in an Iranian population. Iran J Med Sci. 2015;40:170-4.
    [Google Scholar]
  6. . Assessing iron status: Beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1(Suppl 1):S4-8.
    [CrossRef] [Google Scholar]
  7. , , , , . Relationships among serum iron, inflammation, and body mass index in children. Adv Pediatr. 2009;56:135-44.
    [CrossRef] [Google Scholar]
  8. , , , . Factors accounting for high ferritin levels in obesity. Int J Obes (Lond). 2008;32:1665-9.
    [CrossRef] [Google Scholar]
  9. , , , , , , et al. Assessment of iron deficiency in the context of the obesity epidemic: Importance of correcting serum ferritin concentrations for inflammation. Am J Clin Nutr. 2013;98:821-6.
    [CrossRef] [Google Scholar]
  10. . Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men--the third national health and nutrition examination survey. Int J Obes Relat Metab Disord. 2001;25:639-45.
    [CrossRef] [Google Scholar]
  11. , , . The relationship between BMI and iron status in iron-deficient adolescent Iranian girls. Public Health Nutr. 2009;12:2377-81.
    [CrossRef] [Google Scholar]
  12. , , . Association of body mass index with hemoglobin concentration and iron parameters in Iranian population. ISRN Hematol. 2014;2014:525312.
    [CrossRef] [Google Scholar]
  13. , , , , , , et al. Revised IAP growth charts for height, weight and body mass index for 5-to 18-year-old Indian children. Indian Pediatr. 2015;52:47-55.
    [CrossRef] [Google Scholar]
  14. , , , , , , et al. Age-and sex-related percentiles of skinfold thickness, waist and hip circumference, waist-to-hip ratio and waist-to-height ratio: Results from a population-based pediatric cohort in Germany (LIFE child) Obes Facts. 2019;12:25-39.
    [CrossRef] [Google Scholar]
  15. , , . An assessment of the relationship between anthropometric parameters and blood pressure among Polokwane private school children. Children (Basel). 2020;7:29.
    [CrossRef] [Google Scholar]
  16. , . Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension. 2004;44:387-8.
    [CrossRef] [Google Scholar]
  17. . On the use of a pilot sample for sample-size determination. Stat Med. 1995;14:1933-40.
    [CrossRef] [Google Scholar]
  18. . Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93:1-21.
    [CrossRef] [Google Scholar]
  19. , , , , , , et al. Reduced adipose tissue oxygenation in human obesity: Evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009;58:718-25.
    [CrossRef] [Google Scholar]
  20. , , , , , , et al. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell. 2014;157:1339-52.
    [CrossRef] [Google Scholar]
  21. , , , , , , et al. Hypoxia enhances immunosuppression by inhibiting CD4+ effector T cell function and promoting treg activity. Cell Physiol Biochem. 2017;41:1271-84.
    [CrossRef] [Google Scholar]
  22. , , , , . Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol. 2008;38:2412-8.
    [CrossRef] [Google Scholar]
  23. , . Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol. 2019;10:1587.
    [CrossRef] [Google Scholar]
  24. , . Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: Causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13:423-44.
    [CrossRef] [Google Scholar]
  25. , . Elevated adenosine deaminase activity in overweight and obese Indian subjects. Arch Physiol Biochem. 2012;118:1-5.
    [CrossRef] [Google Scholar]
  26. , , . Contributory role of adenosine deaminase in metabolic syndrome. Niger J Physiol Sci. 2013;28:73-6.
    [Google Scholar]
  27. , , , , , . Ferritin, metabolic syndrome and its components: A systematic review and meta-analysis. Atherosclerosis. 2018;275:97-106.
    [CrossRef] [Google Scholar]
  28. , , , , , . Obesity and iron deficiency: A quantitative meta-analysis. Obes Rev. 2015;16:1081-93.
    [CrossRef] [Google Scholar]
  29. , , . Iron in obesity. An ancient micronutrient for a modern disease. Obes Rev. 2010;11:322-8.
    [CrossRef] [Google Scholar]
  30. , , , , , , et al. Association between serum ferritin and hypertension according to the working type in Korean men: The fifth Korean National Health and nutrition examination survey 2010-2012. Ann Occup Environ Med. 2018;30:40.
    [CrossRef] [Google Scholar]
Show Sections

Indian Journal of Physiology and Pharmacology

Copyright Form


Manuscript Number: ___________________
Title of the Manuscript: ________________________________________


I/we certify that I/we have participated sufficiently in the intellectual content, conception and design of this work or the analysis and interpretation of the data (when applicable), as well as the writing of the manuscript, to take public responsibility for it and have agreed to have my/our name listed as a contributor. I/we believe the manuscript represents valid work. Each author confirms they meet the criteria for authorship as established by the ICMJE. Neither this manuscript nor one with substantially similar content under my/our authorship has been published or is being considered for publication elsewhere, except as described in the covering letter. I/we certify that all the data collected during the study is presented in this manuscript and no data from the study has been or will be published separately. I/we attest that, if requested by the editors, I/we will provide the data/information or will cooperate fully in obtaining and providing the data/information on which the manuscript is based, for examination by the editors or their assignees. Financial interests, direct or indirect, that exist or may be perceived to exist for individual contributors in connection with the content of this paper have been disclosed in the cover letter. Sources of outside support of the project are named in the cover letter.


I/We hereby transfer (s), assign (s), or otherwise convey (s) all the commercial copyright ownership, including any and all rights incidental thereto, exclusively to the Journal, in the event that such work is published by the Journal. The Journal shall own the work, including

  1. copyright;
  2. the right to grant permission to republish the article in whole or in part, with or without fee;
  3. the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and
  4. the right to republish the work in a collection of articles in any other mechanical or electronic format.

The author(s) holds the academic rights of the material under the Creative Commons CC BY-NC-SA. This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms. CC BY-NC-SA includes the following elements:


BY: credit must be given to the creator.
NC: Only noncommercial uses of the work are permitted.
SA: Adaptations must be shared under the same terms.


We give the rights to the corresponding author to make necessary changes as per the request of the journal, do the rest of the correspondence on our behalf and he/she will act as the guarantor for the manuscript on our behalf.

All persons who have made substantial contributions to the work reported in the manuscript, but who are not contributors, are named in the Acknowledgment and have given me/us their written permission to be named. If I/we do not include an Acknowledgment that means I/we have not received substantial contributions from non-contributors and no contributor has been omitted.


Name of the author(s) Signature Date signed
Yes/No
Yes/No
Yes/No